47.73.Z - Retail sale of pharmaceutical products
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
82.99.Z - Other business support activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,5 | 1,7 | 1,7 | 0,2 |
Gross profit (loss) | 1,7 | 1,8 | 1,8 | -1,9 |
EBITDA | 1,8 | 1,9 | 1,9 | -0,2 |
Short time liabilities | 0,2 | 0,2 | 0,1 | -22,2 |
Other operating costs | 0 | 0 | 0 | -6,6 |
Equity capital | 6,8 | 7,8 | 8,7 | 11,2 |
Operating profit (EBIT) | 1,7 | 1,8 | 1,7 | -2,8 |
Assets | 7,3 | 8,3 | 9,2 | 10,8 |
Net profit (loss) | 1,7 | 1,8 | 1,8 | -1,9 |
Cash | 1,1 | 0,5 | 0,3 | -31,5 |
Net income from sale | 11,7 | 13,4 | 15,9 | 18,8 |
Liabilities and provisions for liabilities | 0,5 | 0,4 | 0,5 | 3,6 |
Working assets | 2,9 | 3,7 | 4,7 | 28,1 |
Other income costs | 0,2 | 0,1 | 0 | -73,6 |
Depreciation | 0,1 | 0,1 | 0,2 | 34,9 |
% | % | % | p.p. | |
Profitability of capital | 24,6 | 22,8 | 20,1 | -2,7 |
Equity capital to total assets | 93 | 94,7 | 95,1 | 0,4 |
Gross profit margin | 14,3 | 13,3 | 11 | -2,3 |
EBITDA Margin | 15,4 | 14,1 | 11,9 | -2,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 6 | 5 | 3 | -2 |
Current financial liquidity indicator | 14.133506774902344 | 20.791458129882812 | 34.2347297668457 | 13,4 |
Net dept to EBITDA | -0.46158984303474426 | -0.16557127237319946 | -0.1038803681731224 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane